From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
Päätekijät: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Frontiers Media
2021
|
Samankaltaisia teoksia
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
Tekijä: Bowness, P
Julkaistu: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
Tekijä: Shi, H, et al.
Julkaistu: (2020) -
The immunology of Ankylosing Spondylitis
Tekijä: Bowness, P
Julkaistu: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
Tekijä: Voruganti, A, et al.
Julkaistu: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
Tekijä: Fischer, R, et al.
Julkaistu: (2012)